DE69007311D1 - Konjugate. - Google Patents

Konjugate.

Info

Publication number
DE69007311D1
DE69007311D1 DE90301589T DE69007311T DE69007311D1 DE 69007311 D1 DE69007311 D1 DE 69007311D1 DE 90301589 T DE90301589 T DE 90301589T DE 69007311 T DE69007311 T DE 69007311T DE 69007311 D1 DE69007311 D1 DE 69007311D1
Authority
DE
Germany
Prior art keywords
conjugates
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE90301589T
Other languages
English (en)
Other versions
DE69007311T2 (de
Inventor
David John Rowlands
Berwyn Ewart Clarke
Michael James Francis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Publication of DE69007311D1 publication Critical patent/DE69007311D1/de
Application granted granted Critical
Publication of DE69007311T2 publication Critical patent/DE69007311T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE69007311T 1989-02-14 1990-02-14 Konjugate. Expired - Lifetime DE69007311T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898903313A GB8903313D0 (en) 1989-02-14 1989-02-14 Conjugates

Publications (2)

Publication Number Publication Date
DE69007311D1 true DE69007311D1 (de) 1994-04-21
DE69007311T2 DE69007311T2 (de) 1994-06-23

Family

ID=10651663

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69007311T Expired - Lifetime DE69007311T2 (de) 1989-02-14 1990-02-14 Konjugate.

Country Status (11)

Country Link
EP (1) EP0385610B1 (de)
JP (1) JP2858848B2 (de)
AU (1) AU634518B2 (de)
CA (1) CA2009896A1 (de)
DE (1) DE69007311T2 (de)
DK (1) DK0385610T3 (de)
ES (1) ES2062330T3 (de)
GB (1) GB8903313D0 (de)
IE (1) IE64983B1 (de)
NZ (1) NZ232505A (de)
ZA (1) ZA901086B (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0299242A3 (de) * 1987-06-22 1989-01-25 Medico Labs Ag Heterologe, virale, immunogen wirksame Peptidpartikel
EP0491077A1 (de) * 1990-12-19 1992-06-24 Medeva Holdings B.V. Zusammensetzung verwendbar als therapeutisches Mittel gegen chronische virale Leberkrankheiten
EP0563091A1 (de) * 1990-12-20 1993-10-06 SMITHKLINE BEECHAM BIOLOGICALS s.a. Impfstoffe auf basis hepatitis-b-oberflächenantigen
US5607691A (en) * 1992-06-12 1997-03-04 Affymax Technologies N.V. Compositions and methods for enhanced drug delivery
FR2699538B1 (fr) * 1992-12-22 1995-02-03 Agronomique Inst Nat Rech Sous-unité d'une capsule protéique CS31A modifiée par au moins un peptide hétérologue, capsule protéique CS31A et microorganismes portant ces sous-unités; procédés d'obtention et utilisation de ceux-ci.
AU2540897A (en) * 1996-03-21 1997-10-10 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Methods and compositions of chimeric polypeptides for tumor antigen vaccines
EP1054689B1 (de) * 1998-02-12 2003-09-10 Immune Complex, Corporation Strategisch modifizierte hepatitis b kernproteine und ihre derivate
EP1123114B1 (de) 1998-10-21 2005-12-28 THE UNITED STATES GOVERNMENT as represented by THE DEPARTMENT OF HEALTH AND HUMAN SERVICES Virusähnliche partikel zur induktion von autoantikörpern
CN100534529C (zh) 1998-11-30 2009-09-02 希托斯生物技术股份公司 抗原的有序分子呈递，制备及使用的方法
IL143475A0 (en) 1998-12-04 2002-04-21 Biogen Inc Hepatitis b virus core antigen particles and vaccines and pharmaceutical compositions containing the same
WO2001085208A2 (en) 2000-05-05 2001-11-15 Cytos Biotechnology Ag Molecular antigen arrays and vaccines
US7320793B2 (en) 2001-01-19 2008-01-22 Cytos Biotechnology Ag Molecular antigen array
US7094409B2 (en) 2001-01-19 2006-08-22 Cytos Biotechnology Ag Antigen arrays for treatment of allergic eosinophilic diseases
US7128911B2 (en) 2001-01-19 2006-10-31 Cytos Biotechnology Ag Antigen arrays for treatment of bone disease
US7115266B2 (en) 2001-10-05 2006-10-03 Cytos Biotechnology Ag Angiotensin peptide-carrier conjugates and uses thereof
CN1668637B (zh) 2002-07-17 2010-05-26 希托斯生物技术股份公司 使用衍生自ap205外壳蛋白的病毒样颗粒的分子抗原阵列
RU2326693C2 (ru) 2002-07-18 2008-06-20 Цитос Байотекнолоджи Аг Конъюгаты гаптен-носитель и их применение
CA2492930C (en) 2002-07-19 2013-01-08 Cytos Biotechnology Ag Vaccine compositions containing amyloid beta1-6 antigen arrays
US7537767B2 (en) 2003-03-26 2009-05-26 Cytis Biotechnology Ag Melan-A- carrier conjugates
ZA200507063B (en) 2003-03-26 2007-03-28 Cytos Biotechnology Ag Packaging of immunostimulatory oligonucleotides into virus-like particles: Method of preparation and use
US8080642B2 (en) 2003-05-16 2011-12-20 Vical Incorporated Severe acute respiratory syndrome DNA compositions and methods of use
AU2005248361B2 (en) 2004-05-18 2010-03-11 Vical Incorporated Influenza virus vaccine composition and methods of use
GB0424563D0 (en) 2004-11-05 2004-12-08 Novartis Ag Organic compounds
US10279028B2 (en) 2012-04-24 2019-05-07 Ohio State Innovation Foundation Compositions and methods for treating and preventing porcine reproductive and respiratory syndrome
WO2013163337A1 (en) 2012-04-24 2013-10-31 The Ohio State University Compositions and methods for treating and preventing porcine reproductive and respiratory syndrome

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8421282D0 (en) * 1984-08-22 1984-09-26 Connaught Lab Multispecific antigenic proteins
US4882145A (en) * 1986-12-09 1989-11-21 Scripps Clinic And Research Foundation T cell epitopes of the hepatitis B virus nucleocapsid protein
GB8709274D0 (en) * 1987-04-16 1987-05-20 Wellcome Found Peptides

Also Published As

Publication number Publication date
AU634518B2 (en) 1993-02-25
JPH0327400A (ja) 1991-02-05
EP0385610B1 (de) 1994-03-16
IE64983B1 (en) 1995-09-20
DE69007311T2 (de) 1994-06-23
DK0385610T3 (da) 1994-07-25
CA2009896A1 (en) 1990-08-14
IE900502L (en) 1990-08-14
JP2858848B2 (ja) 1999-02-17
EP0385610A1 (de) 1990-09-05
NZ232505A (en) 1992-12-23
ES2062330T3 (es) 1994-12-16
GB8903313D0 (en) 1989-04-05
ZA901086B (en) 1990-11-28
AU4975590A (en) 1990-10-18

Similar Documents

Publication Publication Date Title
FI905602A0 (fi) Fullfaergs tredimensionell projektionsdisplay.
FI891717A (fi) Kvadraturmodulator.
DE69007311T2 (de) Konjugate.
FI914805A0 (fi) Ickegrafitiska taendningsresistanta strukturer.
FI905180A0 (fi) Herbicider haerledda fraon 2-atsolylnikotinat.
FI902428A0 (fi) Dimeriska epipodofyllotoxinglukosidderivat.
FI892737A0 (fi) Massaloesare.
FI902698A0 (fi) Prosessorenhetsnaeten.
FI895931A0 (fi) Ljusutstraolare foer fiskodling.
FI900653A0 (fi) Matningsstiftarrangemang foer en integrerad krets.
NO903662L (no) Koplingsstykke.
NO892183L (no) Kjoelekappe.
FI893436A (fi) Centrifugalpump.
NO904967D0 (no) Alkoksymetyliden-epipodofyllotoksin-glykosider.
FI902491A0 (fi) Anordning foer faksimiloeverfoering.
FI896253A0 (fi) Avstaengningsventil.
FI890024A0 (fi) Patientbaeranordning.
FI895971A0 (fi) Haollare foer vindrutetorkare.
ATE100755T1 (de) Brieflocher.
ATE101099T1 (de) Mikrodosiergeraet.
ATE102114T1 (de) Brieflocher.
ATE103894T1 (de) Indolderivate.
ATE96362T1 (de) Brieflocher.
FI83388B (fi) Bloeja.
ES1012497Y (es) Alternador-depresor.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition